Help
Subscribe


All of GastroHep is now free access! - Click here to register Read For FREE - Our full range of review articles
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Guido Tytgat Profile of Pete Peterson Profile of Peter Cotton Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Simple noninvasive scoring systems for fibrosis in NAFLD

This month's issue of the European Journal of Gastroenterology & Hepatology investigates simple noninvasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels.

News image

Nonalcoholic fatty liver disease is common and many affected individuals have normal-range alanine aminotransferase levels.

Dr Stuart Mc Pherson and colleagues reported that there is a need for a robust screening tool to triage individuals with advanced fibrosis for specialist care.

The research team assessed the performance of noninvasive fibrosis tests in patients with biopsy-proven nonalcoholic fatty liver disease, and normal levels of alanine aminotransferase.

The research team assessed that patients presenting at a fatty liver clinic between 1999 and 2009 were included in the study.

Liver biopsies were assessed using the Kleiner score.

The team of doctors noted that the aspartate aminotransferase alanine aminotransferase/alanine aminotransferase ratio, BARD, FIB-4 and Nonalcoholic fatty liver disease fibrosis scores were calculated.

A total of 305 patients were included.

61% with normal alanine aminotransferase levels could avoid liver biopsy
European Journal of Gastroenterology & Hepatology

The researchers examined that in total, 24% of patients with normal alanine aminotransferase levels, and 17% of those with elevated alanine aminotransferase levels had advanced fibrosis.

The FIB-4 performed best in identifying advanced fibrosis in patients with normal alanine aminotransferase.

The doctors noted that the sensitivity of the AST/alanine aminotransferase ratio and BARD and nonalcoholic fatty liver disease fibrosis scores for advanced fibrosis was good in patients with normal ALT levels, but the specificity was low.

The FIB-4 yielded best results in patients with elevated alanine aminotransferase levels.

Using the FIB-4, 61% of patients with normal alanine aminotransferase levels, and 63% of those with elevated alanine aminotransferase levels could avoid liver biopsy to exclude advanced fibrosis.

In contrast, AST/alanine aminotransferase ratio and BARD and nonalcoholic fatty liver disease scores would have led to a high proportion of patients with mild disease having to undergo a biopsy.

Dr McPherson's team commented, "The FIB-4 yielded good results in patients with normal or elevated alanine aminotransferase levels, reliably excluding advanced fibrosis and reducing the need for liver biopsy."

Eur Journal of Gastroenterol & Hepatol 2013: 25(6): 652-658
12 June 2013

Go to top of page Email this page Email this page to a colleague

 26 November 2014

Advanced search
 26 November 2014 
Fertility in women with celiac disease
 26 November 2014 
Detection of gastric precancerous conditions
 26 November 2014 
Vegetables and garlic and colorectal cancer risk
 25 November 2014 
Esophagogastric junction of children with GERD
 25 November 2014 
Symptom activity index for eosinophilic esophagitis
 25 November 2014 
Placebo response rate in fistulizing Crohn's
 24 November 2014 
Nasoenteric tube feeding in acute pancreatitis
 24 November 2014 
Corticosteroids and infections in elderly-onset IBD
 24 November 2014 
Adhesions in abdominal and pelvic surgery
 21 November 2014 
Hepatic involvement in IgG4-related disease
 21 November 2014 
Mortality of chemoembolization in hepatocellular carcinoma
 21 November 2014 
Skin cancer in ulcerative colitis patients
 20 November 2014 
Global measures in chronic idiopathic constipation
 20 November 2014 
Macrophage activation in alcoholic hepatitis
 20 November 2014 
Covert hepatic encephalopathy and survival
 19 November 2014 
Thiopurine withdrawal in IBD
 19 November 2014 
Esophageal narrowing in esophageal eosinophilia
 19 November 2014 
Second intestinal resection in Crohn's
 18 November 2014 
Colorectal neoplasia and vitamin D
 18 November 2014 
Food-associated changes in the intestinal mucosa in IBS
 18 November 2014 
Alternative medicine use by US adults
 17 November 2014 
Treatment of obesity in primary care settings
 17 November 2014 
Allergy-related diseases and abdominal pain in childhood
 17 November 2014 
Diagnosis of monogenic very early onset IBD
 14 November 2014 
Second intestinal resection in Crohn's
 14 November 2014 
HCC risk in active stage Hep B
 14 November 2014 
Thiopurine and clinical remission in IBD
 13 November 2014 
Antibiotics and risk of new-onset Crohn’s
 13 November 2014 
Chronic Hep C genotype 1 treatment after relapse
 13 November 2014 
Chemoembolization for hepatocellular carcinoma
 12 November 2014 
Risk of hepatocellular carcinoma
 12 November 2014 
Abdominal symptom severity in chronic idiopathic constipation
 12 November 2014 
Screening colonoscopy
 11 November 2014 
Hepatocellular carcinoma in Hep B with nucleotide analogue
 11 November 2014 
Familial colorectal cancer screening
 11 November 2014 
Fecal microbiota transplant for C. diff
 10 November 2014 
STaples IPAA for ulcerative colitis
 10 November 2014 
Blood stream infections in acute liver failure
 10 November 2014 
Ig4-related disease
 07 November 2014 
Host and viral factors in chronic Hep C
 07 November 2014 
Celiac diagnosis without biopsy
 07 November 2014 
Pricing practices of gastroenterologists
 06 November 2014 

Colorectal surgery postdischarge occurrences and readmissions

 06 November 2014 
Thromboprophylaxis in IBD
 06 November 2014 
Steatosis biomarkers in NAFLD
 05 November 2014 
Readmission risk factors for patients with IBD
 05 November 2014 
Hysterectomy and colonoscopy completion
 05 November 2014 
Adalimumab in Crohn's disease
 04 November 2014 
Gut barrier dysfunction and CNS disorders
 04 November 2014 
Hemospray for nonvariceal upper GI bleeding
 04 November 2014 
Sleep duration and ulcerative colitis
 03 November 2014 
Mucosal pathophysiology in HIV and IBD
 03 November 2014 
Managing bleeding gastroduodenal ulcers
 03 November 2014 
Identifying inflammation in ulcerative colitis
 31 October 2014 
Pregnancy complications in celiac disease
 31 October 2014 
Pediatric NAFLD
 31 October 2014 
C. difficile infection with metronidazole
 30 October 2014 
Cirrhosis in women
 30 October 2014 
Costs in newly diagnosed patients with chronic constipation
 30 October 2014 
Constipation and colorectal cancer

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2014 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us